Rare diseases
Investigational molecules
Locations
Back to Italy215 clinical trials in Orbassano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis
ItalyStudy on the Safety and Effects of Luspatercept for Children with Beta Thalassemia
ItalyEfficacy and Safety Study of Paltusotine for Adults with Carcinoid Syndrome due to Well-Differentiated Neuroendocrine Tumors
ItalyOsimertinib and drug combination in metastatic non‑small cell lung cancer with targetable genomic driver alterations
ItalyPhase 3 Study of Enfortumab Vedotin plus Pembrolizumab in Adults with Muscle‑Invasive Bladder Cancer Ineligible for Cystectomy
ItalyItalyA Phase III Randomized Trial of Trilaciclib Dihydrochloride versus Placebo in Adults with Limited‑Stage Small Cell Lung Cancer
ItalyComparison of nivolumab drug combination versus immunotherapy‑TKI sequence in patients with metastatic renal cell carcinoma
ItalyStudy of Hyperthermic Intrathoracic Chemotherapy with Cisplatin and Pleurectomy versus Standard Care in Patients with Malignant Pleural Effusion
ItalyAdvanced hepatocellular carcinoma patients: assessing atezolizumab drug combination and other treatment sequences
ItalyPhase 1/2 Study of Oral TRI-611 in Adults With Advanced ALK‑Positive Non‑Small Cell Lung Cancer
ItalyPhase 3 Study of Taletrectinib as Adjuvant Therapy in Patients with Completely Resected ROS1‑Positive Stage IB‑IIIA Non‑Small Cell Lung Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on lung cancer and mesothelioma treatments, including studies of novel therapeutic combinations and targeted therapies.
Multiple trials evaluating immunotherapy approaches and targeted molecular treatments for advanced stages of cancer.
Research initiatives investigating treatments for blood disorders and related conditions, with particular focus on innovative therapies.
Studies examining new therapeutic approaches for blood disorders and their complications.
Clinical investigations focusing on heart failure prevention and innovative cardiovascular treatments.
Trials evaluating new therapeutic approaches for reducing cardiovascular events and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
